A Study Evaluating the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy

What we are studying

The primary purpose of this research is to investigate the effectiveness of remimazolam, in producing sedation during a bronchoscopy compared with “placebo”, a treatment that looks like the test drug but which contains no active ingredient. Alternatively you may receive treatment with midazolam, a drug that is approved for producing sedation during a bronchoscopy.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Subjects scheduled to undergo a diagnostic or therapeutic bronchoscopy in the bronchoscopy suite
  • American Society of Anesthesiologists Physical Status Score I through III
  • Body Mass Index of less than or equal to 40 kg/m2
  • Female participants must have a negative pregnancy test result as well as the use of birth control during the study period.

What is involved

  • Screening Visit - Physical Examination
  • Blood Draw
  • Urine Collection
  • Height
  • Weight
  • Respiratory Rate
  • Body Temperature
  • Supine 12-lead ECG
  • Questionnaires/Assessments
  • 3-Lead ECG telemetry
  • Supine Heart Rate
  • Blood Pressure
  • Bronchoscopy;


$135.00 - Finish the entire study; $45.00 for each study visit you finish if study is not completed;

Contact Information

Study Coordinator
Penny Spernoga

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.